PGF and preeclampsia: Patients with either suspected preeclampsia or confirmed disease were included, and recent evidence has shown that the biomarker test may perform differently in these 2 groups; while PlGF-based testing is useful as a diagnostic adjunct in patients with suspected preeclampsia,24 test performance for determining need for delivery in seven days is lower in patients with confirmed preeclampsia.25 Further evaluation on biomarker test thresholds and appropriate training for clinicians is needed before these tests are used in clinical practice for patients with established preeclampsia.